Details for New Drug Application (NDA): 010021
✉ Email this page to a colleague
NDA 010021 describes PLACIDYL, which is a drug marketed by Abbvie and is included in one NDA. Additional details are available on the PLACIDYL profile page.
The generic ingredient in PLACIDYL is ethchlorvynol. There is one drug master file entry for this compound. Additional details are available on the ethchlorvynol profile page.
The generic ingredient in PLACIDYL is ethchlorvynol. There is one drug master file entry for this compound. Additional details are available on the ethchlorvynol profile page.
Summary for 010021
| Tradename: | PLACIDYL |
| Applicant: | Abbvie |
| Ingredient: | ethchlorvynol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 010021
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 004
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 007
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
